InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Stuart Iain, Directeur Scientifique. Officer active across 1 company, notably VYNE Therapeutics Inc.. Aggregated, 24 disclosures have been published. Activity tracked since 30 June 2021. The latest transaction was disclosed on 23 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Stuart Iain
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations24 total
15,405 shares@ US$0.89760.045% mcap18.4% of flowCommon StockSEC:0001727756-26-000008:0
2,876 shares@ US$0.59753.1% of flowCommon StockSEC:0001727756-26-000004:0
2,448 shares@ US$0.58012.2% of flowCommon StockSEC:0001727756-26-000002:0
2,453 shares@ US$0.3351.3% of flowCommon StockSEC:0001727756-25-000003:0
2,453 shares@ US$1.656.6% of flowCommon StockSEC:0001415889-25-019058:0
6,044 shares@ US$1.5815.0% of flowCommon StockSEC:0001415889-25-009632:0
4,857 shares@ US$3.3526.5% of flowCommon StockSEC:0001415889-25-000155:0
109 shares@ US$1.880.3% of flowCommon StockSEC:0001415889-24-024382:0
138 shares@ US$1.920.4% of flowCommon StockSEC:0001415889-24-019175:0
157 shares@ US$3.080.8% of flowCommon StockSEC:0001415889-24-010070:0
62,500 shares0Common StockSEC:0001209191-24-000469:0
62,500 shares0Common StockSEC:0001209191-23-058818:0
1,184 shares@ US$3.837.3% of flowCommon StockSEC:0001209191-23-051948:0
151 shares@ US$4.101.0% of flowCommon StockSEC:0001209191-23-041120:0
480 shares@ US$3.082.3% of flowCommon StockSEC:0001209191-23-022801:0
1,720 shares@ US$0.150.4% of flowCommon StockSEC:0001209191-23-001098:0
1,719 shares@ US$0.2230.7% of flowCommon StockSEC:0001209191-22-052356:0
1,719 shares@ US$0.3891.1% of flowCommon StockSEC:0001209191-22-040788:0
3,469 shares@ US$0.653.1% of flowCommon StockSEC:0001209191-22-022530:0
75,000 shares0Common StockSEC:0001209191-22-020066:0
1,250 shares@ US$1.021.7% of flowCommon StockSEC:0001209191-22-000858:0
1,480 shares@ US$1.392.7% of flowCommon StockSEC:0001209191-21-058519:0
60,859 shares0Common StockSEC:0001209191-21-054836:0
3,083 shares@ US$3.5117.0% of flowCommon StockSEC:0001209191-21-044979:0
24 of 24 declarations
About Stuart Iain
Stuart Iain is Chief Scientific Officer at VYNE Therapeutics Inc. He has 23 filings in total, and among the sampled recent filings the most common transaction nature is Tax withholding, with buy and sell amounts of 0, over the period from 2021-07-02 to 2026-04-02.
